Tranquinol en es it fr

Tranquinol Brand names, Tranquinol Analogs

Tranquinol Brand Names Mixture

  • No information avaliable

Tranquinol Chemical_Formula


Tranquinol RX_link

No information avaliable

Tranquinol fda sheet

Tranquinol msds (material safety sheet)

Tranquinol Synthesis Reference

No information avaliable

Tranquinol Molecular Weight

309.469 g/mol

Tranquinol Melting Point

< 25 oC

Tranquinol H2O Solubility

Soluble as HCl salt

Tranquinol State


Tranquinol LogP


Tranquinol Dosage Forms

Tablets (oral, 1 mg)

Tranquinol Indication

Used for the symptomatic treatment of parkinsonism.

Tranquinol Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Tranquinol Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Tranquinol side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Tranquinol Patient Information

Tranquinol Organisms Affected

Humans and other mammals